The American College of Cardiology and American Heart Association issued updated practice guidelines for the management of ...
The 2025 guideline introduces notable updates including refined recommendations for dual antiplatelet therapy, cardiogenic ...
The American College of Cardiology and the American Heart Association today released an updated clinical practice guideline for managing individuals experiencing acute coronary syndrome (ACS). The ...
Acute coronary syndromes include chest pain and heart attack resulting from unstable coronary artery cholesterol plaque causes clots to form that reduce or block blood flow to the heart muscle.
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...
Native Hawaiian and Pacific Islander adults were 10% more likely to be diagnosed with coronary heart disease than non-Hispanic white adults in 2014. Historically, Asian American, Native Hawaiian ...
Until Saturday, the doctors will bring themselves up to date in the fields of heart failure, coronary heart disease ... Bernhard Metzler Over 1000 acute heart attacks are treated at the Innsbruck ...
ABSTRACT: Acute coronary syndrome (SCA) is the clinical manifestation of myocardial suffering due to ischemia. Through this study, we aim to describe the management of acute coronary syndromes in the ...
Notably, the control group had a higher prevalence of pre-existing coronary artery disease (83% vs ... Laboratory analysis of venous blood at the acute phase showed significantly elevated hs ...
Ottawa, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The global clinical trials market size was valued at USD 120.98 billion in 2024 and is expected to hit around USD 186.09 billion by 2034 with a CAGR of 4. ...
Mar. 5, 2025 — Research shows that a common type of diabetes medication could help cancer patients make a better long-term recovery. Many cancer patients go on to develop heart failure ...
Risk stratification in acute coronary syndromes aims to identify those patients at greatest risk of recurrent ischaemic events who might benefit prognostically from further investigation and treatment ...